Technical challenges in developing biosimilar antibodies
Since originator recombinant proteins are getting off patent, biosimilar molecules are entering
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Since originator recombinant proteins are getting off patent, biosimilar molecules are entering
For authors and organisers
Find the right journal for your paper and submit your manuscript.